Why cookies? Simply because they are used to help the website function, to improve your browser experience, to integrate with social media and to show relevant advertisements tailored to your interests. Click 'I understand' to accept cookies and go directly to the site or click 'Change settings' to change your cookie preferences. Click here
While the majority of COPD patients have EFL, care teams have never had a COPD NIV ventilation therapy that dynamically and automatically targets EFL. BiPAP A40 EFL is the first and only NIV therapy precision-crafted to abolish EFL in hypercapnic COPD patients. It screens, detects and auto-optimizes pressure – to treat comfortably and redefine what is possible in managing COPD.
You are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
Continue